{"name":"Zydus Lifesciences Limited","slug":"zydus-lifesciences-limited","ticker":"","exchange":"","domain":"zyduslifesciences.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Pertuzumab (Perjeta®)","genericName":"Pertuzumab (Perjeta®)","slug":"pertuzumab-perjeta","indication":"HER2-positive metastatic breast cancer (in combination with trastuzumab and chemotherapy)","status":"phase_3"},{"name":"Pertuzumab (ZRC-3277)","genericName":"Pertuzumab (ZRC-3277)","slug":"pertuzumab-zrc-3277","indication":"HER2-positive metastatic breast cancer (in combination with trastuzumab and chemotherapy)","status":"phase_3"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Desidustat Oral Tablet","genericName":"Desidustat Oral Tablet","slug":"desidustat-oral-tablet","indication":"Anemia in chronic kidney disease patients not on dialysis","status":"phase_3"}]}],"pipeline":[{"name":"Desidustat Oral Tablet","genericName":"Desidustat Oral Tablet","slug":"desidustat-oral-tablet","phase":"phase_3","mechanism":"Desidustat inhibits prolyl hydroxylase domain-containing protein (PHD) enzymes to stabilize hypoxia-inducible factor (HIF) and increase endogenous erythropoietin production.","indications":["Anemia in chronic kidney disease patients not on dialysis","Anemia in dialysis-dependent chronic kidney disease patients"],"catalyst":""},{"name":"Pertuzumab (Perjeta®)","genericName":"Pertuzumab (Perjeta®)","slug":"pertuzumab-perjeta","phase":"phase_3","mechanism":"Pertuzumab is a monoclonal antibody that binds to HER2 and blocks its dimerization with other HER receptors, preventing cancer cell growth signaling.","indications":["HER2-positive metastatic breast cancer (in combination with trastuzumab and chemotherapy)","HER2-positive early breast cancer (neoadjuvant and adjuvant settings)"],"catalyst":""},{"name":"Pertuzumab (ZRC-3277)","genericName":"Pertuzumab (ZRC-3277)","slug":"pertuzumab-zrc-3277","phase":"phase_3","mechanism":"Pertuzumab is a monoclonal antibody that binds to HER2 and blocks its dimerization with other HER receptors, preventing cancer cell growth signaling.","indications":["HER2-positive metastatic breast cancer (in combination with trastuzumab and chemotherapy)","HER2-positive gastric or gastroesophageal junction cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPZEZTb2M4ck9MZHprLVBFWGR4ZFdhTHdxaXQzZGpXNW1ycjNmdzVtdjJfNjZmNmhmdDkwREd3ek01MDJnc0JfN0FZVWhJeUQ0X2k2SHNCeTBDQnJncV9relBNZlBDZ3hWcm1yejFWSjRGV0dhQnExbnNBVy1YVmMtMWhuT19yRzAxS2ZnMW9td3EzOWFMWGJkTXk2S1JlZkZLdndUbVlQTC1mRmszSUZxc2gzWXNsS2JrRVRDWkRwWTlPVW1Ram1rVFpFcWlfYXJpSjBvbDlkMFRYSmtFNHRINVJ6XzU?oc=5","date":"2026-03-30","type":"pipeline","source":"MSN","summary":"Zydus Lifesciences honoured at NDTV HR Excellence Awards | Celebrating leadership in pharma - MSN","headline":"Zydus Lifesciences honoured at NDTV HR Excellence Awards | Celebrating leadership in pharma","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-18","type":"regulatory","source":"NDTV Profit","summary":"Zydus, Torrent Pharma To Co-Market Semaglutide Injection Used For Weight Loss Treatment - NDTV Profit","headline":"Zydus, Torrent Pharma To Co-Market Semaglutide Injection Used For Weight Loss Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQRmhCem9qR2FFM2c4WVM0UFVvSFJCQTk4T0I0Ymo4RlF4eTZhdF80TDdvRDc2UGU1Q0lyMUFNbzlFVXdLOFpIa0NfYTVPdlI2My0tMWZ5SGxlZUhKVDIzalp2My1zR3NLVndMaGpkOFk5X19qU1JHMHM1bW9BNzZiSnN4RWRiMmR1NkpkY1dER1VYeUdGRkNKVVU5Mzh3MXZReHBEX0pvTU81R2U4QjFPa0lYY0RQVkJiSW43cHItNnVoWlpSV0JKbW5kMnd3TFhZcEw2Q3gwZlZWUQ?oc=5","date":"2026-03-17","type":"regulatory","source":"lupin.com","summary":"Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India - lupin.com","headline":"Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-02","type":"regulatory","source":"medicaldialogues.in","summary":"Zydus Lifesciences Secures USFDA Final Approvals for Ivermectin and Dapsone Tablets - medicaldialogues.in","headline":"Zydus Lifesciences Secures USFDA Final Approvals for Ivermectin and Dapsone Tablets","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPX3lBcEgwM2ZNYkZOX1VuVFgzVmh1WE9LVl9LSXFUdERSMzJMSFYzQnhMWE1yYm5UdjRoUEVwZjRXX1BxYTNMUjRBOHNkQy1Zc3YyVFEwaXoxcFJpMGRJZDU4ZUROX1QzbzlMVkdscDZLSTZKanJKUTd6YnZncTlUeGZCRkxnVE5TWkxzcHZrLU9wZXQwX3BBeXNNcE5VNE1TdXNRemJQRnc0TG5vVTFqaUNFRmFKRzMtNXo0dkZ2NlBRa29wd3dsVzFfWQ?oc=5","date":"2026-02-12","type":"pipeline","source":"reuters.com","summary":"India's Zydus Life agrees $120 million settlement with Astellas over bladder drug - reuters.com","headline":"India's Zydus Life agrees $120 million settlement with Astellas over bladder drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxQQVRmOGRGblkwblRlZVBQUUZaZDRIMjV2WEJTWjdyUm83NEdUcTd3ZjIteVBMMVhVbTRCdjl4VUNLYXc3eDNYNUpwMU5RQmktMUt0X2l3RG56TzRaVUk4bnREblQ0Rmw4eEtPbW9FbnpES2lHSzdvbFo2MWg1LS1WYVYteXd0enVhUzBIaG5VN0VVazcyUlAtYlQwS3FpTGhaQnpCUk1PMzZ4Tk9CNWVDWjB3Zm1BWUlVRjVSNHcwY3hQWHFFUDRmV01ZOXJrSnUyd1lHaQ?oc=5","date":"2026-02-11","type":"patent","source":"scanx.trade","summary":"Zydus Lifesciences Settles US Patent Dispute with Astellas for USD 120 Million - scanx.trade","headline":"Zydus Lifesciences Settles US Patent Dispute with Astellas for USD 120 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNN25DWVdFVUw2TU9VNW9MMF8zMTRubTVUTG12SDdGbm5IdzZvTjEyZDlGc1BFbnJ1RG12NllWelRGTUdvTzMxa25zYTF2Z0ZMTjZRNjBINGk2Sy1JWmZDUnVQbjRrWWY4TDktaVJjSDF3cnRReWxldFhiVWFJbjhIZy03OWZva2NLRDl5Z2U0eXplYWNHblVXQTRabXJVMHlHRHRobUQxVWhqV0lPaEp0NXdjYzU2NmlFcVdIdg?oc=5","date":"2026-01-15","type":"deal","source":"Contract Pharma","summary":"Zydus LifeSciences Acquires Biologics Manufacturing Facilities from Agenus - Contract Pharma","headline":"Zydus LifeSciences Acquires Biologics Manufacturing Facilities from Agenus","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-15","type":"regulatory","source":"ET Pharma","summary":"Zydus Lifesciences gets USFDA nod for generic blood disorder drug - ET Pharma","headline":"Zydus Lifesciences gets USFDA nod for generic blood disorder drug","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-04","type":"pipeline","source":"simplywall.st","summary":"Owning 75% in Zydus Lifesciences Limited (NSE:ZYDUSLIFE) means that insiders are heavily invested in the company's future - simplywall.st","headline":"Owning 75% in Zydus Lifesciences Limited (NSE:ZYDUSLIFE) means that insiders are heavily invested in the company's futur","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxORUpYaEZua1lDMlNFRDNWUUpfTVFoVHlUaGtTczZTY2xRVkR3QkdQcWlnRVpuaW9rRXhudmpEcVZBTkU0UzJjV3NwdWtGamlWeks0MUY3cHF0dVNWaTR6QVBscVRKQ1c4MWdKUEhLR3d6dERHXzZZYmtaMXpJSllyTjhPTE5BNWRRdHE4VjRxQnc4VmJMbXd5WDY5ZVBNX1JzOE4xbVdGWmdjcjZxcnQxLTdwcmRlU2J3SmZhRVdvQ2RPNndXQl9rS2JYRVAxc01BRkdPc2RqdDVYbHZoanZ6YTdSRjladXJDaHVZTHRwZnFHNkpPTzZLeTB1NUloOTJhcndxYUpwdTE2b2hJbmJFWWR6aEhhTklJMUloeWZob0VBMm5aWlVsU0ZBUXFTZGFNN00wRkJudkJnc2J0R0VCag?oc=5","date":"2025-11-26","type":"pipeline","source":"PR Newswire","summary":"Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market - PR Newswire","headline":"Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2025-11-26","type":"pipeline","source":"The Economic Times","summary":"Zydus Lifesciences inks licensing, commercialisation pact with RK Pharma - The Economic Times","headline":"Zydus Lifesciences inks licensing, commercialisation pact with RK Pharma","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-26","type":"regulatory","source":"Business Standard","summary":"Zydus Lifesciences shares rise after USFDA nod, RK Pharma licensing deal - Business Standard","headline":"Zydus Lifesciences shares rise after USFDA nod, RK Pharma licensing deal","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":3},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}